RT Journal Article
SR Electronic
T1 Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002990
DO 10.1136/jitc-2021-002990
VO 9
IS 8
A1 Wagner, Michael J
A1 Othus, Megan
A1 Patel, Sandip P
A1 Ryan, Chris
A1 Sangal, Ashish
A1 Powers, Benjamin
A1 Budd, G Thomas
A1 Victor, Adrienne I
A1 Hsueh, Chung-Tsen
A1 Chugh, Rashmi
A1 Nair, Suresh
A1 Leu, Kirsten M
A1 Agulnik, Mark
A1 Sharon, Elad
A1 Mayerson, Edward
A1 Plets, Melissa
A1 Blanke, Charles
A1 Streicher, Howard
A1 Chae, Young Kwang
A1 Kurzrock, Razelle
YR 2021
UL http://jitc.bmj.com/content/9/8/e002990.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.